What is the price of Autobio Diagnostics Co., Ltd. (603658)

The price of Autobio Diagnostics Co., Ltd. (603658) is $4.86

What is the market cap of Autobio Diagnostics Co., Ltd. (603658)

The market cap of Autobio Diagnostics Co., Ltd. (603658) is $2.78B

Autobio Diagnostics Co., Ltd. (603658) Operating Margin

Autobio Diagnostics Co., Ltd. specializes in the full lifecycle of clinical diagnostic products, from their initial research and development to manufacturing and market distribution. Their diverse offerings encompass a range of reagents for immunoassay, biochemistry, microbiology, and in-vitro diagnostics (IVD). Additionally, they provide advanced automated and semi-automated instrumentation, alongside comprehensive medical laboratory solutions. Notable immunoassay products include the AutoLumo A2000 Plus automatic chemiluminescence immunoassay analyzer, automated microplate chemiluminescent enzyme immunoassays, LUmo luminometers, PHOmo microplate readers, and iWO microplate washers. Within their microbiology division, they offer automated blood culture systems, blood culture bottles, AUTOMIC strips, and mycoplasma IES. Founded in 1998, the company originally operated as Lifeclone Diagnostics Co., Ltd. before adopting its current name, Autobio Diagnostics Co., Ltd., in 2003. Headquartered in Zhengzhou, China, it functions as a subsidiary of Zhengzhou Auto Industrial Co., Ltd.

Year	Operating Margin	Change
Not enough data for the provided dates.

Year

Operating Margin

Change

Not enough data for the provided dates.

Company	Operating Margin	Operating Margin Difference	Country
Thermo Fisher Scientific Inc. TMO.US	17.69%	-	US
Danaher Corporation DHR.US	20.42%	-	US
WuXi AppTec Co., Ltd. 603259.SS	0.00%	-	CN
Natera, Inc. NTRA.US	-10.70%	-	US
Agilent Technologies, Inc. A.US	21.50%	-	US

Company

Operating Margin

Operating Margin Difference

Country